$AKRX Headlines Speculators live by the sword, die by

New Post Public Reply Private Reply Replies (0) Message Board

Sep 28, 2014 at 10:48 AM

$AKRX Headlines

Speculators live by the sword, die by the sword 3:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 10:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 11:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 12:34 p.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 8:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 10:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 12:11 p.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 11:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 6:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 5:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 8:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 12:07 p.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 7:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 12:09 p.m. Dec. 23, 2011 - Michael Ashbaugh
S&P, Nasdaq retest major support 12:51 p.m. Dec. 12, 2011 - Michael Ashbaugh
U.S. markets survive test of major support 10:57 a.m. Nov. 2, 2011 - Michael Ashbaugh
Akorn rallies on earnings, M&A deal 1:59 p.m. Aug. 2, 2011 - Val Brickates Kennedy
Drug stocks slip; Emergent rallies 1:28 p.m. May 26, 2011 - Val Brickates Kennedy
Drug stocks gain; Derma, Elan climb 3:51 p.m. May 25, 2011 - Val Brickates Kennedy

Meet 5 Top Stocks With Rising Earnings Estimates 7:02 a.m. Sept. 26, 2014 - Investors Business Daily
Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog 6:10 p.m. Sept. 23, 2014 - Zacks.com
Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog 4:55 p.m. Sept. 23, 2014 - Zacks.com
Acquisition-Hungry Akorn Sets Up Potential Buy Area 5:10 p.m. Sept. 22, 2014 - Investors Business Daily
Analysts Are Warming to These 5 Stocks 9:25 a.m. Sept. 22, 2014 - InvestorPlace.com
IBD 50: Akorn Aims For $1 Billion In Sales 5:35 p.m. Sept. 19, 2014 - Investors Business Daily
IBD 50 Stocks Setting Up, Including These 5 Medicals 5:35 p.m. Sept. 19, 2014 - Investors Business Daily
Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog 4:30 p.m. Sept. 18, 2014 - Zacks.com
Will Drugmaker Akorn Have A Healthy Bounce Up? 11:09 a.m. Sept. 18, 2014 - Investors Business Daily
Stocks with Upgraded Broker Ratings - Screen of the Week 3:57 a.m. Sept. 16, 2014 - Zacks.com
AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog 5:05 p.m. Sept. 12, 2014 - Zacks.com
5 Top Stocks With Rising Earnings Estimates 7:02 a.m. Sept. 12, 2014 - Investors Business Daily
Wall Street Breakfast: EU Places New Sanctions On Russia, U.S. To Follow 6:32 a.m. Sept. 12, 2014 - Seeking Alpha
Akorn In Second Test Of 10-Week Line 5:09 p.m. Sept. 11, 2014 - Investors Business Daily
Akorn reportedly eyeing tax inversion deal 4:07 p.m. Sept. 11, 2014 - Seeking Alpha
Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog 4:45 p.m. Sept. 10, 2014 - Zacks.com
10 Stocks with 5-Year Returns of 1,500%-Plus 5:10 a.m. Sept. 10, 2014 - InvestorPlace.com
Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog 5:20 p.m. Sept. 8, 2014 - Zacks.com
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog 5:05 p.m. Sept. 5, 2014 - Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch 4:06 p.m. Sept. 5, 2014 - Investors Business Daily

Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 8:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 8:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 9:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 6:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 6:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 11:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 11:11 a.m. June 20, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development 4:05 p.m. June 16, 2014 - BusinessWire - BZX
Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte 8:00 a.m. June 5, 2014 - PR Newswire - PRF
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
Akorn to Acquire VersaPharm for $440 Million 9:19 a.m. May 9, 2014 - BusinessWire - BZX
Akorn Reports 2014 First Quarter Results 7:03 a.m. May 6, 2014 - BusinessWire - BZX
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Actavis to Acquire Four Products from Akorn 4:15 p.m. April 17, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of Hi-Tech Pharmacal 9:21 a.m. April 17, 2014 - BusinessWire - BZX
Repligen Corporation Set to Join the S&P SmallCap 600 5:53 p.m. April 15, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa General’s Innovation Excellence Earns No. 20 Spot

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Monib Zirvi's Dermatology Excellence Honored in 2026

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

AbbVie's Bold Leap in Menstrual Migraine Treatment

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Helio Fred Garcia Honored by Diversity Action Alliance

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Mobile Iron IV Expansions: Targeting Texas Health Needs

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Rare Collectibles Highlight Morphy's Auction on Oct 4

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Red-Eye Flights Surge, Driven By Western U.S. Routes

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Atli Launches: AI-Powered eSIM Revolutionizes Travel

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Veho's Role in Redefining Beauty E-Commerce Delivery

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Diaper Affordability: A Hidden Crisis, Taxpayer Burden

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...